These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5757162)

  • 21. [Late results of radioiodine resection in hyperthyroidism].
    Haffner B; Frischauf H
    Wien Klin Wochenschr; 1970 Apr; 82(15):272-5. PubMed ID: 5437080
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in the electrolyte balance in thyrotoxicosis patients associated with surgical intervention].
    Kryzhanovskiĭ AI
    Khirurgiia (Mosk); 1966 Sep; 42(9):55-7. PubMed ID: 6000782
    [No Abstract]   [Full Text] [Related]  

  • 23. [Correlation between the protein-bound iodine and butanol-extracted iodine in the blood serum of patients with diffuse toxic goiter during treatment with mercazolyl].
    Okulov VB
    Probl Endokrinol (Mosk); 1969; 15(4):5-8. PubMed ID: 4189655
    [No Abstract]   [Full Text] [Related]  

  • 24. [Late results of fractionates radioiodine therapy. Controlled studies in hyperthreoses following 2-11 years].
    Reinwein D; Miss H; Horster FA; Berger H; Klein E; Oberdisse K
    Dtsch Med Wochenschr; 1968 Dec; 93(50):2416-20. PubMed ID: 4177324
    [No Abstract]   [Full Text] [Related]  

  • 25. [Surgical treatment of toxic goiter compared with treatment with I-131].
    Abundalu HA; Urca I; Lewitus Z
    J Chir (Paris); 1972 Apr; 103(4):395-400. PubMed ID: 4677795
    [No Abstract]   [Full Text] [Related]  

  • 26. [MODERN THERAPY OF HYPERTHYROIDISM].
    POLICZER M
    Magy Belorv Arch (1955); 1963 Jun; 16():115-23. PubMed ID: 14068047
    [No Abstract]   [Full Text] [Related]  

  • 27. [Radioisotope therapy of hyperthyroidism].
    Englaro GC; Zecchin R
    Minerva Med; 1973 Apr; 64(25):1347-56. PubMed ID: 4740096
    [No Abstract]   [Full Text] [Related]  

  • 28. [Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach. Clinical results].
    Giovanella L; De Palma D; Ceriani L; Vanoli P; Garancini S; Tordiglione M; Tarolo GL
    Radiol Med; 2000 Dec; 100(6):480-3. PubMed ID: 11307510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [On the problems of radioiodine therapy of malignant goiter].
    zur Mühlen A von ; Emrich D
    Verh Dtsch Ges Inn Med; 1967; 73():375-9. PubMed ID: 5591780
    [No Abstract]   [Full Text] [Related]  

  • 30. PROBLEM OF HYPOTHYROIDISM AFTER I131 THERAPY OF HYPERTHYROIDISM.
    STANBURY JB; DEGROOT LJ
    N Engl J Med; 1964 Jul; 271():195-6. PubMed ID: 14158359
    [No Abstract]   [Full Text] [Related]  

  • 31. [RARE LATE COMPLICATIONS IN HYPERTHYROID PATIENTS TREATED WITH RADIOIODINATED I-131 ON BASIS OF MORE THAN 3500 CASES].
    GENNARELLI L; LENTI R
    Minerva Med; 1964 Feb; 55():397-8. PubMed ID: 14139682
    [No Abstract]   [Full Text] [Related]  

  • 32. [Our experiences with radioiodine therapy in recurrent strumas].
    Garten C; Hennig K
    Dtsch Gesundheitsw; 1972 Oct; 27(41):1952-5. PubMed ID: 4637248
    [No Abstract]   [Full Text] [Related]  

  • 33. [The level of potassium and sodium in the blood and urine of patients with toxic goiter].
    Tatarkina ND
    Ter Arkh; 1969 Jul; 41(7):93-6. PubMed ID: 5374419
    [No Abstract]   [Full Text] [Related]  

  • 34. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sodium and potassium in erythrocytes (author's transl)].
    Nagaki J; Teraoka M; Hirota Y
    Rinsho Byori; 1973 Aug; 21(8):653-7. PubMed ID: 4796712
    [No Abstract]   [Full Text] [Related]  

  • 36. [Disturbed body oxygen supply in patients with various forms of goiter according to blood gas findings].
    Kovalev MM; Savchenko AA
    Probl Endokrinol (Mosk); 1967; 13(3):3-7. PubMed ID: 5633229
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of radioiodine therapy of manifest hyperthyroidism and autonomous struma with euthyroidism].
    Berding G; Schicha H
    Nuklearmedizin; 1990 Aug; 29(4):158-65. PubMed ID: 2216811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
    Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship of the thyroid scintiscan to the therapeutic effects of 131I in hyperthyroidism with diffuse goiter.
    Tjoe SL; Levine B; Wieland RG; Chen JC
    J Nucl Med; 1971 Dec; 12(12):804-7. PubMed ID: 5118350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.